Walid Warda

429 total citations
8 papers, 222 citations indexed

About

Walid Warda is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Walid Warda has authored 8 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Walid Warda's work include CAR-T cell therapy research (6 papers), Virus-based gene therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Walid Warda is often cited by papers focused on CAR-T cell therapy research (6 papers), Virus-based gene therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Walid Warda collaborates with scholars based in France, Lebanon and United States. Walid Warda's co-authors include Christophe Ferrand, Marina Deschamps, Étienne Daguindau, Éric Deconinck, Jacob Piehler, Suman Mitra, Ignacio Moraga, Stephan Wilmes, Xavier Roussel and Mark R. Walter and has published in prestigious journals such as Cancer Research, Gene Therapy and Science Signaling.

In The Last Decade

Walid Warda

8 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Walid Warda France	7	132	82	61	42	42	8	222
Tommaso Sconocchia Austria	10	116 0.9×	86 1.0×	91 1.5×	27 0.6×	22 0.5×	20	252
Tiina Hannunen Finland	4	139 1.1×	100 1.2×	125 2.0×	50 1.2×	46 1.1×	4	285
Alexandria Van Scoyk United States	7	146 1.1×	100 1.2×	93 1.5×	24 0.6×	39 0.9×	8	249
Amirhosein Maali Iran	7	85 0.6×	98 1.2×	48 0.8×	26 0.6×	21 0.5×	26	219
Timothy Voorhees United States	8	152 1.2×	53 0.6×	55 0.9×	17 0.4×	32 0.8×	37	240
Matteo Doglio Italy	8	150 1.1×	50 0.6×	116 1.9×	22 0.5×	30 0.7×	19	245
Chengfei Pu China	8	202 1.5×	87 1.1×	96 1.6×	21 0.5×	60 1.4×	19	277
Patrycja Wawrzyniecka United Kingdom	6	239 1.8×	72 0.9×	110 1.8×	19 0.5×	75 1.8×	16	300
Jessica Hulitt United States	3	82 0.6×	59 0.7×	79 1.3×	44 1.0×	41 1.0×	4	187
Rebecca Epperly United States	7	171 1.3×	83 1.0×	72 1.2×	40 1.0×	59 1.4×	30	241

Countries citing papers authored by Walid Warda

Since Specialization

Citations

This map shows the geographic impact of Walid Warda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Warda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Warda more than expected).

Fields of papers citing papers by Walid Warda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid Warda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Warda. The network helps show where Walid Warda may publish in the future.

Co-authorship network of co-authors of Walid Warda

This figure shows the co-authorship network connecting the top 25 collaborators of Walid Warda. A scholar is included among the top collaborators of Walid Warda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walid Warda. Walid Warda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Warda, Walid, et al.. (2023). CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans. Current Research in Translational Medicine. 71(2). 103385–103385. 12 indexed citations

2.

Warda, Walid, et al.. (2023). RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells. Gene Therapy. 30(9). 706–713. 22 indexed citations

3.

Guiot, Mélanie, et al.. (2022). Coated recombinant target protein helps explore IL-1RAP CAR T-cell functionality in vitro. Immunologic Research. 71(2). 276–282. 4 indexed citations

4.

Warda, Walid, et al.. (2021). Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch. Cancer Gene Therapy. 28(12). 1365–1375. 25 indexed citations

5.

Wilmes, Stephan, Walid Warda, Elizabeth Pöhler, et al.. (2020). Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses. Science Signaling. 13(649). 60 indexed citations

6.

Roussel, Xavier, Étienne Daguindau, Ana Berceanu, et al.. (2020). Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics. Frontiers in Oncology. 10. 599933–599933. 16 indexed citations

7.

Bruyère, Diane, Amandine Etcheverry, Marc Aubry, et al.. (2020). EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas. Cancers. 12(12). 3649–3649. 15 indexed citations

8.

Warda, Walid, Fabrice Larosa, Éric Deconinck, et al.. (2018). CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor–Engineered T Cells. Cancer Research. 79(3). 663–675. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact